Liver allograft. Its use in chronic active hepatitis with macronodular cirrhosis, hepatitis B surface antigen.
about
Orthotopic liver transplantation for patients with hepatitis B virus-related liver diseaseHistocompatibility and liver transplant outcome. Does HLA exert a dualistic effect?Current status of hepatic transplantation.Immunosuppression for liver transplantation in HCV-infected patients: mechanism-based principles.Evolution of liver transplantation.Incidence and severity of acute allograft rejection in liver transplant recipients treated with alfa interferonA concise update on the status of liver transplantation for hepatitis B virus: the challenges in 2002.Pancreatitis following liver transplantationFifteen years of clinical liver transplantation.Infections complicating orthotopic liver transplantation: a study emphasizing graft-related septicemia.Evolution of hepatitis B virus liver disease after hepatic replacement. Practical and theoretical considerations.Orthotopic liver transplantation in ninety-three patientsTypes, causes, and therapies of hepatitis occurring in liver transplant recipients.Liver transplantation for hepatitis B: what have we learned and what does the future hold?Recurrent hepatitis B in liver allograft recipients. Differentiation between viral hepatitis B and rejection.Post-transplant recurrent hepatitis B viral liver disease. Viral-burden, steatoviral, and fibroviral hepatitis B.
P2860
Q34094783-291E2318-2213-4A9B-B273-2C3114C2DA9EQ34206976-EEF676FE-2D74-45F3-8427-8BC7964816E7Q34207236-7C004ED7-12F7-4B83-B5C6-BE4DFBFFB938Q34232434-43864807-9DCC-421E-8094-C9388182A0E2Q34275840-BFCFDCCC-F0FB-4F3A-AF37-CBA3F5191022Q34423385-711E463B-E8A6-4C12-94BF-17D214F6FF86Q34499694-15900FDE-29C3-489F-906D-4320A90DA325Q34561561-5078C16E-A873-4B13-BCB6-3BDF77389A0AQ34965480-519DACFA-45B8-4C66-8227-ED925F090E97Q35683699-1C454ED3-99E6-412B-AF21-F12A9DAECF75Q35811558-59EC0B29-6C7A-47FD-87A7-D81080DB8440Q37019777-D76166EE-F09B-4894-B5FD-5F84DB685016Q40881579-BC06C64F-7610-40B1-A771-805DC9951A32Q40979372-0B85B944-1C5E-44AE-855A-31E896449863Q42752143-BF68C677-3F97-43B5-AEF1-80C9728A5CB4Q42755608-1FF64C16-4F40-4E5A-917F-04F78C8C3D77
P2860
Liver allograft. Its use in chronic active hepatitis with macronodular cirrhosis, hepatitis B surface antigen.
description
1979 nî lūn-bûn
@nan
1979 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1979 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1979年の論文
@ja
1979年論文
@yue
1979年論文
@zh-hant
1979年論文
@zh-hk
1979年論文
@zh-mo
1979年論文
@zh-tw
1979年论文
@wuu
name
Liver allograft. Its use in ch ...... , hepatitis B surface antigen.
@ast
Liver allograft. Its use in ch ...... , hepatitis B surface antigen.
@en
Liver allograft. Its use in ch ...... , hepatitis B surface antigen.
@nl
type
label
Liver allograft. Its use in ch ...... , hepatitis B surface antigen.
@ast
Liver allograft. Its use in ch ...... , hepatitis B surface antigen.
@en
Liver allograft. Its use in ch ...... , hepatitis B surface antigen.
@nl
prefLabel
Liver allograft. Its use in ch ...... , hepatitis B surface antigen.
@ast
Liver allograft. Its use in ch ...... , hepatitis B surface antigen.
@en
Liver allograft. Its use in ch ...... , hepatitis B surface antigen.
@nl
P2093
P2860
P1433
P1476
Liver allograft. Its use in ch ...... , hepatitis B surface antigen.
@en
P2093
A G Redeker
C W Putnam
G Schröter
J L Corman
K A Porter
R L Peters
S Iwatsuki
P2860
P356
10.1001/ARCHSURG.1979.01370250077016
P577
1979-01-01T00:00:00Z